These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1360230

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Overexpression of the p185erB-2 tyrosine kinase growth factor receptor: control or chaos.
    Gerwin BI.
    Am J Respir Cell Mol Biol; 1992 Apr; 6(4):357-8. PubMed ID: 1347998
    [No Abstract] [Full Text] [Related]

  • 43. [Amplification and expression of oncogenes in human malignant tumors--organ or tissue specificity and prognosis].
    Ueda M, Shimizu N, Abe O.
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1579-81. PubMed ID: 2573817
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Correlation of ErbB2 gene status, mRNA and protein expression in a panel of >100 human tumor xenografts of different origin.
    Kuesters S, Maurer M, Burger AM, Metz T, Fiebig HH.
    Onkologie; 2006 Jun; 29(6):249-56. PubMed ID: 16770086
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo.
    Stern DF, Kamps MP, Cao H.
    Mol Cell Biol; 1988 Sep; 8(9):3969-73. PubMed ID: 2464744
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Oncogenic potential and normal function of the proto-oncogenes encoding protein-tyrosine kinases.
    Yamamoto T, Akiyama T, Semba K, Yamanashi Y, Inoue K, Yamada Y, Sukegawa J, Toyoshima K.
    Basic Life Sci; 1990 Sep; 52():321-39. PubMed ID: 2158295
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Oral cancer progression and c-erbB-2/neu proto-oncogene expression.
    Hou L, Shi D, Tu SM, Zhang HZ, Hung MC, Ling D.
    Cancer Lett; 1992 Aug 31; 65(3):215-20. PubMed ID: 1355405
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The ras gene family and human carcinogenesis.
    Bos JL.
    Mutat Res; 1988 May 31; 195(3):255-71. PubMed ID: 3283542
    [Abstract] [Full Text] [Related]

  • 56. The oncogene and its potential role in carcinogenesis.
    Wong-Staal F.
    Arch Toxicol Suppl; 1985 May 31; 8():61-72. PubMed ID: 3006636
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. The neu (c-erbB-2) oncogene.
    Maguire HC, Greene MI.
    Semin Oncol; 1989 Apr 31; 16(2):148-55. PubMed ID: 2565604
    [Abstract] [Full Text] [Related]

  • 59. c-erbB-2 promoter-specific DNA-binding protein isolated from human breast cancer tissues displays mitogenic activity.
    Sarkar FH, Smith MR, Hoover T, Princler G, Crissman JD, Visscher DW, Longo DL, Kung HF, Raziuddin.
    J Biol Chem; 1994 Apr 22; 269(16):12285-9. PubMed ID: 7909319
    [Abstract] [Full Text] [Related]

  • 60. ROS receptor tyrosine kinase: a new potential target for anticancer drugs.
    El-Deeb IM, Yoo KH, Lee SH.
    Med Res Rev; 2011 Sep 22; 31(5):794-818. PubMed ID: 20687158
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.